9786138966562 - Risks and management of two opposite GI-pathophysiological damage: Risk factors and appropriate nutritional/therapeutic strategy for gastrointestinal pathophysiolog... (8 resultados)

Condición: New.

Taschenbuch. Condición: Neu. Risks and management of two opposite GI-pathophysiological damage | Risk factors and appropriate nutritional/therapeutic strategy for gastrointestinal pathophysiological disorders | Kais Rtibi | Taschenbuch | Englisch | 2021 | Scholars' Press | EAN 9786138966562 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Common functional gastroenterological disorders such as constipation and diarrhea are widely associated with a decrease in life quality. The purpose of this project is to provide information about the risk factors of both disorders such as chemotherapy, radiotherapy, inflammatory bowel disease, post-operative bowel management, the lifestyle of food habits, diabetes, obesity, dysbiosis, brain-gut axis dysfunction, psychosocial factors, and COVID-19. More recently, COVID-19 had at least one gastrointestinal symptom. The laxative stimulants are used to promote the intestinal mucosa, improving the secretion of normal water and electrolytes which encourages peristalsis activity. But, long-term use of these agents may cause many side effects. Non-pharmacological and pharmacological treatments have been used to manage these affections. Many natural compounds with laxative and benefit effects as well as the use of probiotics, prebiotics, and synbiotics have been reported as novel therapeutic strategies for the treatment of constipation/diarrhea, and the improvement of the gastrointestinal structure/function and composition. 52 pp. Englisch.

Condición: New. Print on Demand.

Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Rtibi KaisDoctorate in Biology, specialty of PhysioNutrition, obtained in 2016 at the Faculty of Sciences of Tunis, El-Manar University. Currently, research assistant at the Unit of Functional Physiology and Valorization of Bioresour.

Condición: New. PRINT ON DEMAND.

Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Common functional gastroenterological disorders such as constipation and diarrhea are widely associated with a decrease in life quality. The purpose of this project is to provide information about the risk factors of both disorders such as chemotherapy, radiotherapy, inflammatory bowel disease, post-operative bowel management, the lifestyle of food habits, diabetes, obesity, dysbiosis, brain-gut axis dysfunction, psychosocial factors, and COVID-19. More recently, COVID-19 had at least one gastrointestinal symptom. The laxative stimulants are used to promote the intestinal mucosa, improving the secretion of normal water and electrolytes which encourages peristalsis activity. But, long-term use of these agents may cause many side effects. Non-pharmacological and pharmacological treatments have been used to manage these affections. Many natural compounds with laxative and benefit effects as well as the use of probiotics, prebiotics, and synbiotics have been reported as novel therapeutic strategies for the treatment of constipation/diarrhea, and the improvement of the gastrointestinal structure/function and composition.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 52 pp. Englisch.

Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Common functional gastroenterological disorders such as constipation and diarrhea are widely associated with a decrease in life quality. The purpose of this project is to provide information about the risk factors of both disorders such as chemotherapy, radiotherapy, inflammatory bowel disease, post-operative bowel management, the lifestyle of food habits, diabetes, obesity, dysbiosis, brain-gut axis dysfunction, psychosocial factors, and COVID-19. More recently, COVID-19 had at least one gastrointestinal symptom. The laxative stimulants are used to promote the intestinal mucosa, improving the secretion of normal water and electrolytes which encourages peristalsis activity. But, long-term use of these agents may cause many side effects. Non-pharmacological and pharmacological treatments have been used to manage these affections. Many natural compounds with laxative and benefit effects as well as the use of probiotics, prebiotics, and synbiotics have been reported as novel therapeutic strategies for the treatment of constipation/diarrhea, and the improvement of the gastrointestinal structure/function and composition.